The Centre’s infrastructure support is directed towards enabling translational research designed to lead to rapid patient benefit. It supports all programmes and tumour types within the Centre by leveraging the development, curation and characterisation of resources such as new experimental model systems or searchable databases, and by increasing capacity in areas including high throughput screening and preclinical trials.
Key areas/contacts:
| Operations Manager (for general information and advice): Liz Musgrove, Wolfson Wohl Cancer Research Centre Tel: 0141 330 7282, Email: liz.musgrove@glasgow.ac.uk |
| High throughput screens: Emma Shanks, Beatson Institute Link to more information on developing screening projects |
| Preclinical trials: Owen Sansom & Jen Morton, Beatson Institute Link to more information on developing pre-clinical trial projects |
| Histology: Colin Nixon, Beatson Institute |
| Biomarkers: Fiona Thomson, Director, Translational Pharmacology Lab, Wolfson Wohl Cancer Research Centre |
| Genomics/Informatics: Liz Musgrove, Wolfson Wohl Cancer Research Centre Tel: 0141 330 7282, Email: liz.musgrove@glasgow.ac.uk |
| Biospecimens: Liz Musgrove, Wolfson Wohl Cancer Research Centre Tel: 0141 330 7282, Email: liz.musgrove@glasgow.ac.uk |